Skyrocketing demand for slimming drugs like Ozempic, Saxenda, & Wegovy
by NL Times
NL Times— The demand for appetite-repressing medications like Ozempic, Saxenda, and Wegovy is skyrocketing in the Netherlands, the Telegraaf reports based on figures from pharmaceuticals. The newspaper links the high demand to increasing obesity and weight issues in the country.
dailym.ai—THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush. Pharma will usher in four obesity drugs in 2027 alone in billion-dollar expansion. Global obesity drug market is projected to hit $100 billion by 2030, analysts say. READ MORE: Weight loss drug in trials burns fat
Global News—Wegovy set to launch in Canada. What to know about the weight-loss drug. Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.
dailym.ai—Women are reporting 'Ozempic breasts' while taking weight-loss drugs. Plastic surgeons say the rapid weight loss can also cause the breasts to sag. Ozempic users have opened up about experiencing shifts in breast size. READ MORE: Can weight loss drugs cause facial aging? Experts views